[Combined use of reminyl (galanthamine) and ovestin (oestradiol) for the treatment of cognitive disorders in women with hypoestrogenic syndrome].
The efficacy of a combined therapy with reminyl and ovestin in low doses used for pharmacocorrection of cognitive disorders in women after total ovariectomy has been studied. The results show a pronounced efficacy of the proposed combined therapy as compared to the standard hormonal replacement therapy in women with hypoestrogenic syndrome, which is confirmed by a significant decrease in the expression of mental impairments evaluated using the BCRS, CCSE, and MMSE methods.
Sapronov
N S
NS
Fedotova
Iu O
IuO
Masalova
O O
OO
Losev
N A
NA
D000328:Adult; D003072:Cognition Disorders / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004964:Estriol / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000097:blood* / Q000627:therapeutic use; D005260:Female; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010052:Ovariectomy; D013577:Syndrome
D004967:Estrogens; D005702:Galantamine; D004964:Estriol